Loss-of-function pathogenic variants in MRAP2 are related to monogenic hyperphagic obesity associated with hyperglycemia and hypertension, contrasting with the other monogenic forms of obesity that present generally with low blood pressure and normal glucose tolerance. Here, MRAP2 is linked to obesity due to melanocortin 4 receptor deficiency.